Introduction:
Esiflo 250 Transcaps is a prescription medicine manufactured by Lupin Ltd. It contains a combination of Salmeterol (50mcg) and Fluticasone Propionate (250mcg). This medication is commonly used to treat conditions such as asthma and chronic obstructive pulmonary disease (COPD). Esiflo 250 Transcaps comes in a packaging of 30 transcaps in 1 bottle with an MRP of ₹406.7.
Uses:
Esiflo 250 Transcaps is primarily used for the treatment of asthma and COPD. It helps in reducing inflammation and opening up the airways to facilitate easier breathing for individuals suffering from these respiratory conditions.
Price:
The market price for Esiflo 250 Transcaps is ₹406.7 for a pack of 30 transcaps in 1 bottle. Prices may vary based on location and pharmacy.
Dosage:
The dosage of Esiflo 250 Transcaps should be determined by a healthcare professional based on the individual’s condition and medical history. It is important to follow the prescribed dosage instructions carefully to ensure optimal treatment outcomes.
Benefits:
– Reduction of inflammation in the airways
– Improved breathing and relief from symptoms of asthma and COPD
Side Effects:
Some common side effects of Esiflo 250 Transcaps may include:
– Nausea
– Vomiting
– Respiratory tract infection
– Fungal infection of mouth
– Sore throat
– Headache
– Hoarseness of voice
– Cough
– Musculoskeletal (bone, muscle, or joint) pain
– Increased heart rate
It is important to consult a healthcare provider if any of these side effects persist or worsen.
Active Ingredients:
The active ingredients in Esiflo 250 Transcaps are Salmeterol (50mcg) and Fluticasone Propionate (250mcg). These ingredients work together to help manage respiratory conditions by reducing inflammation and opening up the airways.
Pharmacological Properties:
The pharmacological properties of Esiflo 250 Transcaps involve the mechanism of action of its active ingredients, Salmeterol and Fluticasone Propionate. Salmeterol is a long-acting beta agonist that helps relax the airway muscles, while Fluticasone Propionate is a corticosteroid that reduces inflammation in the airways.
Indications:
Esiflo 250 Transcaps is indicated for the treatment of asthma and COPD in patients who require the combination therapy of a long-acting beta agonist and a corticosteroid to control their symptoms and improve lung function.
Contraindications:
Esiflo 250 Transcaps is contraindicated in individuals with a known hypersensitivity to any of the ingredients present in the medication. It should also be avoided in patients with certain medical conditions such as untreated fungal, bacterial, or parasitic infections.
Drug Interactions:
Esiflo 250 Transcaps may interact with certain medications, including other respiratory drugs, antifungal medications, and some antibiotics. It is important to inform your healthcare provider about all the medications you are currently taking to avoid any potential drug interactions.
Patient Counseling:
Patients using Esiflo 250 Transcaps should be advised to:
– Follow the prescribed dosage instructions carefully
– Store the medication in a cool, dry place away from direct sunlight
– Keep the medication out of reach of children
– Seek medical attention in case of severe side effects or worsening symptoms
Clinical Evidence:
Clinical studies have shown the efficacy of Esiflo 250 Transcaps in the management of asthma and COPD. These studies have demonstrated the benefits of the combination therapy of Salmeterol and Fluticasone Propionate in improving lung function and reducing symptoms in patients with these respiratory conditions.
Frequently Asked Questions:
Q: Can Esiflo 250 Transcaps be used for children?
A: Esiflo 250 Transcaps is generally not recommended for use in children without the guidance of a healthcare provider.
Q: How long does it take for Esiflo 250 Transcaps to show results?
A: The time it takes for Esiflo 250 Transcaps to show results may vary from person to person. It is important to use the medication as prescribed for optimal benefits.
Q: Are there any dietary restrictions while taking Esiflo 250 Transcaps?
A: There are no specific dietary restrictions associated with Esiflo 250 Transcaps. However, it is important to maintain a healthy diet as advised by your healthcare provider.
Q: Can Esiflo 250 Transcaps be used during pregnancy?
A: Pregnant women should consult their healthcare provider before using Esiflo 250 Transcaps to assess the potential risks and benefits of the medication during pregnancy.
Q: Is it safe to drive or operate machinery while taking Esiflo 250 Transcaps?
A: Esiflo 250 Transcaps may cause dizziness or other side effects that can affect your ability to drive or operate machinery. It is important to exercise caution until you know how the medication affects you.
<HTML Tags have been added to the content to enhance readability and structure.
MRP:
₹406.7
Manufacturer:
Lupin Ltd
Salt:
Salmeterol (50mcg) + Fluticasone Propionate (250mcg),
How to UseEsiflo 250 Transcaps:
Trancaps must not be swallowed. Check the label for directions before use. Place the capsule at the base of transhaler, not in the mouthpiece. Twist the mouthpiece completely until your hear a click and breathe in deeply through the mouthpiece. Hold your breath for up to 10 seconds. If some powder remains in the transhaler repeat the process.
Side Effects of Esiflo 250 Transcaps:
Nausea,Vomiting,Respiratory tract infection,Fungal infection of mouth,Sore throat,Headache,Hoarseness of voice,Cough,Musculoskeletal (bone, muscle or joint) pain,Increased heart rate,
Alternate Medicines for Esiflo 250 Transcaps:
Prescription Required Status:
Prescription Required
Type of Selection:
30 transcaps in 1 bottle
Chemical Class:
Not Listed
Habit Forming:
No
Therapeutic Class:
RESPIRATORY
Action Class:
Not Listed
. Please note, this information is for educational purposes only and not intended as medical advice.
